CSIMarket
 


Kaya Holdings Inc  (AFAI)
Other Ticker:  
 

Kaya Holdings Inc's Working Capital Ratio

AFAI's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth


Current Liabilities decreased faster than Kaya Holdings Inc's Current Assets, this led to improvement in Kaya Holdings Inc's Working Capital Ratio to 0.02, Working Capital Ratio remained below Kaya Holdings Inc average.

Within Major Pharmaceutical Preparations industry 503 other companies have achieved higher Working Capital Ratio than Kaya Holdings Inc in third quarter 2023. While Working Capital Ratio total ranking has improved so far during the III Quarter 2023 to 4682, from total ranking in the second quarter 2023 at 5081.

Explain Working Capital Ratio
How much in Current Assets AFAI´s has?
What is the value of AFAI´s Current Liabilities?


AFAI Working Capital Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Change -39.66 % 84.06 % 10.51 % 28.78 % 6.83 %
Y / Y Current Assets Change 48.38 % 49.25 % -76.05 % -90.74 % -52.64 %
Working Capital Ratio MRQ 0.02 0.01 0.01 0.01 0.01
AFAI's Total Ranking # 4682 # 5081 # 4852 # 5155 # 5298
Seq. Current Liabilities Change -22.4 % 3.34 % -6.98 % -19.1 % 136.7 %
Seq. Current Assets Change -17.6 % 131.86 % 10.34 % -29.62 % -17.11 %



Working Capital Ratio third quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 504
Healthcare Sector # 1032
Overall Market # 4682


Working Capital Ratio Statistics
High Average Low
0.62 0.07 0
(Dec 31 2015)   (Sep 30 2013)




Financial Statements
Kaya Holdings Inc's Current Liabilities $ 8 Millions Visit AFAI's Balance sheet
Kaya Holdings Inc's Current Assets $ 0 Millions Visit AFAI's Balance sheet
Source of AFAI's Sales Visit AFAI's Sales by Geography


Cumulative Kaya Holdings Inc's Working Capital Ratio

AFAI's Working Capital Ratio for the trailling 12 Months

AFAI Working Capital Ratio

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities TTM Growth -39.66 % 84.06 % 10.51 % 28.78 % 6.83 %
Y / Y Current Assets TTM Growth 48.38 % 49.25 % -76.05 % -90.74 % -52.64 %
Working Capital Ratio TTM 0.01 0.01 0.01 0.01 0.03
Total Ranking TTM # 4009 # 4258 # 4448 # 5055 # 4810
Seq. Current Liabilities TTM Growth -22.4 % 3.34 % -6.98 % -19.1 % 136.7 %
Seq. Current Assets TTM Growth -17.6 % 131.86 % 10.34 % -29.62 % -17.11 %


On the trailing twelve months basis In spite of the year on year decrease in AFAI's Current Liabilities to $7.77 millions, cumulative Working Capital Ratio to 0.01 below the AFAI average Working Capital Ratio.
Working Capital Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 502 other companies have achieved higher Working Capital Ratio than Kaya Holdings Inc. While Working Capital Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2023 from 3757 to 3960.

Explain Working Capital Ratio
How much in Current Assets AFAI´s has?
What is the value of AFAI´s Current Liabilities?

TTM Working Capital Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 503
Healthcare Sector # 1048
Within the Market # 4682


trailing twelve months Working Capital Ratio Statistics
High Average Low
0.21 0.04 0.01
(June 30. 2016)   (Jun 30 2021)




Companies with similar Working Capital Ratio in the quarter ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Working Capital RatioSep 30 2023 MRQ Current AssetsSep 30 2023 MRQ Current Liabilities
Avenue Therapeutics Inc   0.04 $ 0.192  Millions$ 5.024  Millions
Bioxytran Inc   0.03 $ 0.080  Millions$ 2.333  Millions
Regen Biopharma Inc  0.02 $ 0.131  Millions$ 5.308  Millions
Innovation1 Biotech Inc   0.02 $ 0.073  Millions$ 3.287  Millions
Hst Global Inc   0.02 $ 0.002  Millions$ 0.093  Millions
Oncotelic Therapeutics Inc   0.02 $ 0.366  Millions$ 17.111  Millions
Skinvisible Inc   0.02 $ 0.053  Millions$ 3.244  Millions
Kaya Holdings Inc  0.02 $ 0.123  Millions$ 7.771  Millions
Novaccess Global Inc   0.01 $ 0.062  Millions$ 7.861  Millions
Axim Biotechnologies Inc   0.01 $ 0.032  Millions$ 4.278  Millions

Date modified: 2023-11-21T22:12:05+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com